Penumbra, Inc. ( PEN) - Key Metrics
PEN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $9.83 | $1.21 | $2.21 | $1.74 |
| 2025Q3 | $9.08 | $1.17 | $1.49 | $1.08 |
| 2025Q2 | $8.74 | $1.17 | $1.16 | $0.76 |
| 2025Q1 | $8.41 | $1.02 | $1.27 | $0.92 |
PEN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 64.34 |
| 2025Q3 | ? | 53.98 |
| 2025Q2 | ? | 55.04 |
| 2025Q1 | ? | 65.73 |
PEN Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.57% | ? |
| 2025Q4 | 0.56% | ? |
| 2025Q3 | 0.42% | ? |
| 2025Q2 | 0.29% | ? |
| 2025Q1 | 0.34% | ? |
PEN
Price: $318.18
52 week price:
Earnings Per Share: 4.35 USD
P/E Ratio: 74.08
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 268800
Ebitda: 1.8 millionMarket Capitalization: 12.6 billion